Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content
Fig. 2 | Alzheimer's Research & Therapy

Fig. 2

From: HCN2 deficiency correlates with memory deficits and hyperexcitability of dCA1 pyramidal neurons in Alzheimer’s disease

Fig. 2

Chemogenetic inhibition of dCA1 PNs improves cognitive functions of hAPP-J20 mice. (A) A representative image showing the expression of the AAV virus microinjected into the dCA1 of J20/CaMKIIα-Cre mice, red: mCherry, blue: DAPI. Scale bar, 500 μm. (B) Representative traces of action potentials recorded in dCA1 PNs before (baseline) and after bath application of CNO (10 µM) and washout of CNO. (Red traces represent the rheobase). (C) The rheobase of dCA1 PNs was higher after CNO treatment (n = 11 cells from 4 mice). Unpaired t-test: t (10) = 3.231, p = 0.0090. **p < 0.01. (D) The numbers of spikes generated in dCA1 PNs in response to depolarizing current injections were significantly decreased after CNO treatment (n = 14 cells from 5 mice). Two-way ANOVA: drug (CNO), F (1, 13) = 24.93, p = 0.0002; current step, F (10, 130) = 125.5, p < 0.0001; interaction, F (10, 130) = 2.957, p = 0.0022; **p < 0.01, ***p < 0.001 with Bonferroni’s post-hoc test. (E) A summary plot in response to 100 pA depolarizing current step showing a significant decrease in the excitability of dCA1 PNs after CNO treatment (n = 10 cells from 4 mice). One-way ANOVA with Bonferroni’s post-hoc test: F (1.77, 15.93) = 15.97, p = 0.0002. **p < 0.01. (F) Path traces of mice and the percentage of alternations in Y-maze test from hAPP-J20 mice expressing mCherry or hM4Di after CNO administration (mCherry, n = 9; hM4Di, n = 9). hAPP-J20 mice expressing hM4Di showed the increased alternations. Unpaired t-test: t (16) = 3.873, p = 0.0013. **p < 0.01. (G) The total arm entries of Y-maze test from hAPP-J20 mice expressing mCherry or hM4Di after CNO administration (mCherry, n = 9; hM4Di, n = 9). Unpaired t-test: t (16) = 0.1362, p = 0.8934. (H) The sociability in three chamber tests from hAPP-J20 mice expressing mCherry or hM4Di after CNO administration (mCherry, n = 9; hM4Di, n = 9). Unpaired t-test: t (16) = 1.905, p = 0.0749. (I) The social novelty in three chamber tests from hAPP-J20 mice expressing mCherry or hM4Di after CNO administration (mCherry, n = 13; hM4Di, n = 9). hAPP-J20 mice expressing hM4Di displayed an increased discrimination index compared with hAPP-J20 mice expressing mCherry. Unpaired t-test: t (20) = 2.107, p = 0.0479. *p < 0.05

Back to article page